Securities
We're currently building out coverage for Swiss-listed stocks (SIX Swiss Exchange). Other markets will follow.

SIGA Technologies Inc

5y streak
US8266741029 · SIGANASDAQ · US · Healthcare · Stock

SIGA Technologies is a commercial-stage biopharmaceutical company focused on developing and commercializing antiviral drugs for serious infectious diseases, with an emphasis on biodefense. Its lead approved product, TPOXX (tecovirimat), is an antiviral treatment for smallpox and related orthopoxvirus infections. The company primarily sells TPOXX to the U.S. government under procurement contracts with the Strategic National Stockpile.

Dividend Yield

TTM · NASDAQ

Last Dividend

0.60

USD · 2026-05-16

5Y Growth

CAGR

Frequency

Irregular

Years Paid

5

consecutive

Not Cut

1

consecutive yrs

Grown

consecutive yrs

Listings

Exchange Ticker Currency Yield TTM
NASDAQ primary
SIGA USD

Annual Dividends

2026 USD 1.20
2022
2023
2024
2025
2026

Annual dividend per share · 5 years of data

Advertisement

Dividend Yield History

Loading yield history…
0.0%3.3%6.7%10.0%

Dividend History

Ex-Date Pay-Date Amount Type
16.05.202606.06.20260.60 USDOrdinary
14.02.202607.03.20260.60 USDOrdinary
16.11.202507.12.20250.60 USDOrdinary
16.05.202506.06.20250.60 USDOrdinary
16.11.202407.12.20240.60 USDOrdinary
16.08.202406.09.20240.60 USDOrdinary
16.05.202406.06.20240.60 USDOrdinary
16.11.202307.12.20230.45 USDOrdinary
16.08.202306.09.20230.45 USDOrdinary
16.05.202306.06.20230.45 USDOrdinary
14.02.202307.03.20230.45 USDOrdinary
16.11.202207.12.20220.45 USDOrdinary
16.08.202206.09.20220.45 USDOrdinary
16.05.202206.06.20220.45 USDOrdinary